In five patients with mtDNA deletions with a progressive external ophtalmoplegia phenotype (PEO), the MAD induced progressive muscle pain and muscle fiber necrosis after 2 weeks of diet (116)
Weve seen countless examples of medications that caused problems in animal studies but were perfectly safe in humansand vice versa
#PBM #pharmacy #healthinsurance #costsavings Serve You Rx Justin Jasniewski #HeadsUpAdviser To view or add a comment, sign in Cigna says it's working with Novo Nordisk and Lilly to adjust GLP1 drug pricing after the White House deal Expect pricing pressure and margin risk for NVO/LLY and volatility for CI as payers push rebates, formulary shifts and tighter coverage
[1] Used together, these two approaches may offer something that neither provides alone: a framework for addressing both the hormonal drivers and the metabolic consequences of menopause simultaneously
Lillys Zepbound, approved in November 2023 as the Indiana-based drug giants answer to Novo Nordisks Wegovy, showed 21% average weight loss after 72 weeks for its highest dose in its Phase 3 trial, and a mid-stage study of another Lilly experimental medicine, called retatrutide, showed 24% weight loss after just 48 weeks
Ayurvedic seers made provisions new formulations that could be made fully in accordance to ayurvedic precepts in order to address new imbalances in the future